Three-Pronged attack on deadly lung pressure disease
NCT ID NCT07266519
Summary
This study is testing whether starting treatment with three different medications right away can better control a serious lung blood vessel disease called pulmonary arterial hypertension (PAH). It will involve 25 adults newly diagnosed with PAH who will take the drug combination for 24 weeks. The main goal is to see if this approach reduces resistance in the lung's blood vessels, which is a key measure of disease severity.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION (PAH) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.